EGFR and cancer: Proteomic analysis of proteins pulled-down from various EGFR-overexpressing cancer cells using short oligonucleotide probes, conjugated to 1,2-dicarba-closo-dodecaborane (1,2-DCDDB, [C2B10H12]) and [(3,3′-Iron-1,2,1′,2′-dicarbollide)−] (FESAN, [Fe(C2B9H11)2]−), evidenced that boron cage binds to EGFR subdomains.